The Shadow of Influence: New CIA Memo Reveals Pfizer Board Member’s Role in Shaping Early COVID-19 Intelligence on September 12, 2026 Posted by
A New Frontier in Neurology: FDA Approves Zanvastro for Rare Alexander Disease on September 12, 2026 Posted by
The Evolution of a Veteran: How Paul George is Redefining Longevity with the Boston Celtics on September 12, 2026 Posted by
The Oncology Crisis: How Drug Shortages are Reshaping Cancer Care in America on September 12, 2026 Posted by
The Sound of Silence: Why the Pro-Vaccine Movement Lost Its Joy—and How to Get It Back on September 12, 2026 Posted by
Unlocking the Blueprint of Human Sight: How Fetal Development Shapes Our Sharpest Vision on September 12, 2026 Posted by
The Silent Synergy: How Abdominal Obesity and Vitamin D Deficiency Create a Deadly Health Trap for Aging Adults on September 12, 2026 Posted by
The Shadow of Influence: New CIA Memo Reveals Pfizer Board Member’s Role in Shaping Early COVID-19 Intelligence on September 12, 2026 Posted by
A New Frontier in Neurology: FDA Approves Zanvastro for Rare Alexander Disease on September 12, 2026 Posted by
The Evolution of a Veteran: How Paul George is Redefining Longevity with the Boston Celtics on September 12, 2026 Posted by
The Oncology Crisis: How Drug Shortages are Reshaping Cancer Care in America on September 12, 2026 Posted by
Posted in Sleep Health Beyond the Latency Threshold: Why ‘Microsleeps’ Are Redefining Narcolepsy Treatment on July 19, 2026
Posted in Sleep Health Beyond Wakefulness: How Orexin Agonists Are Redefining the 24-Hour Treatment of Narcolepsy Type 1 on July 18, 2026
Posted in Sleep Health The Equity Gap in Narcolepsy Care: New Data Reveals Disparities in Treatment Access on July 15, 2026
Posted in Sleep Health The Hidden Burden: Cognitive Impairment in Narcolepsy and Idiopathic Hypersomnia on July 14, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Takeda’s Oveporexton Shows Promise in Phase 3 Clinical Trials on July 6, 2026
Posted in Sleep Health The Hidden Burden: New Study Reveals Cognitive Impairment as a Primary Driver of Disability in Narcolepsy and Idiopathic Hypersomnia on July 5, 2026
Posted in Sleep Health A New Dawn for Narcolepsy: Takeda’s Oveporexton Shows Transformative Potential in Phase 3 Trials on June 24, 2026
Posted in Sleep Health Beyond the Wakefulness Gap: How Cognitive Impairment Redefines Life with Narcolepsy and Idiopathic Hypersomnia on June 23, 2026
Posted in Sleep Health Decoding Narcolepsy: New Research Unlocks Potential for Simpler, More Accessible Diagnostic Testing on June 18, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
